Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905718-21-001027
Filing Date
2021-08-12
Accepted
2021-08-12 19:35:48
Documents
2
Period of Report
2021-08-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 16012
2 POWER OF ATTORNEY poa.htm EX-24 5974
  Complete submission text file 0000905718-21-001027.txt   23437
Mailing Address 1042-B NORTH EL CAMINO REAL, SUITE 430 ENCINITAS CA 92024
Business Address
HALE DAVID F (Reporting) CIK: 0001024004 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40739 | Film No.: 211169269
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3525 DEL MAR HEIGHTS RD., #332 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #332 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Issuer) CIK: 0001853816 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations